239 related articles for article (PubMed ID: 32695478)
21. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of an autophagy-related prognostic model for predicting survival based on TCGA and ICGC database in hepatocellular carcinoma patients.
An LN; Du L; Wang LL; Chen J; Wang XR; Duan JP
J Gastrointest Oncol; 2022 Dec; 13(6):3154-3168. PubMed ID: 36636069
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Zhong Q; Zhou L; Zhu D
J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
[TBL] [Abstract][Full Text] [Related]
25. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
26. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
27. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
Liu C; Wu W; Xu M; Mi J; Xu L; Wang R
Biomed Res Int; 2021; 2021():1028158. PubMed ID: 34423028
[TBL] [Abstract][Full Text] [Related]
30. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
31. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
[No Abstract] [Full Text] [Related]
32. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
Li SR; Man QW; Liu B
Front Oncol; 2022; 12():943945. PubMed ID: 36452497
[TBL] [Abstract][Full Text] [Related]
33. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
[No Abstract] [Full Text] [Related]
36. Development and Validation of a Necroptosis-Related Prognostic Model in Head and Neck Squamous Cell Carcinoma.
Zhang Z; Hu X; Qiu D; Sun Y; Lei L
J Oncol; 2022; 2022():8402568. PubMed ID: 35222645
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma.
Liu S; Liu W; Ding Z; Yang X; Jiang Y; Wu Y; Liu Y; Wu J
Front Mol Biosci; 2022; 9():912620. PubMed ID: 36339718
[No Abstract] [Full Text] [Related]
38. Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma.
Feng S; Liu H; Dong X; Du P; Guo H; Pang Q
Bioengineered; 2021 Dec; 12(2):9692-9708. PubMed ID: 34696669
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
40. Identification of Three Autophagy-Related Long Non-Coding RNAs as a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature.
Guo Y; Yang PT; Wang ZW; Xu K; Kou WH; Luo H
Front Oncol; 2020; 10():603864. PubMed ID: 33575215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]